Compare $ALT vs $PBYI | Chartloom

Compare

$ALT vs $PBYI

Altimmune Inc · Puma Biotechnology Inc

ALT

Altimmune Inc

PBYI

Puma Biotechnology Inc

Compare $ALT vs $PBYI

Comparing Altimmune Inc and Puma Biotechnology Inc

ALTAltimmune Inc

PBYIPuma Biotechnology Inc

ALTAltimmune Inc

Market cap

$508M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

55.0%

YTD performance

-25.6%

52W performance

-33.6%

FCF yield

-15.1%

PBYIPuma Biotechnology Inc

Market cap

$524M

P/E (TTM)

20.26x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-2.9%

YTD performance

78.3%

52W performance

96.7%

FCF yield

7.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALT

PBYI

Detailed metrics comparison

ALT

Altimmune Inc

PBYI

Puma Biotechnology Inc

Market Cap

ALT$508M

PBYI$524M

Enterprise Value

ALT$479M

PBYI$487M

Price

ALT$2.61

PBYI$10.29

P/E Ratio

ALTN/A

PBYI20.26x

P/S Ratio

ALT16,373.12x

PBYI2.26x

EV/Sales

ALT15,461.31x

PBYI2.11x

EV/EBITDA

ALT0.00x

PBYI10.51x

P/B Ratio

ALT1.12x

PBYI3.54x

P/FCF Ratio

ALTN/A

PBYI12.75x

EV/FCF

ALT-6.26x

PBYI11.86x

PEG Ratio

ALTN/A

PBYIN/A

Forward P/E (NTM)

ALTN/A

PBYIN/A

Forward P/S (NTM)

ALTN/A

PBYIN/A

Revenue (TTM)

ALT$31K

PBYI$231M

Revenue Growth (YoY)

ALT55.0%

PBYI-2.9%

Forward Rev Growth

ALT217.1%

PBYI-1.4%

Gross Margin (TTM)

ALT0.0%

PBYI74.8%

Operating Margin (TTM)

ALT0.0%

PBYI13.2%

EBITDA Margin (TTM)

ALT-322987.1%

PBYI17.7%

Net Margin (TTM)

ALT-296000.0%

PBYI11.6%

FCF Margin (TTM)

ALT-246974.2%

PBYI17.8%

Net Income (TTM)

ALT$-92M

PBYI$27M

FCF (TTM)

ALT$-77M

PBYI$41M

EPS (TTM)

ALT-$0.49

PBYI$0.51

ROE (TTM)

ALT-3141.0%

PBYI20.8%

ROA (TTM)

ALT-2696.0%

PBYI13.3%

ROIC (TTM)

ALT-2853.0%

PBYI18.4%

Cash

ALT$63M

PBYI$37M

Debt

ALT$35M

PBYI$0

Net Cash/Debt

ALT$28M

PBYI$37M

Current Ratio (TTM)

ALT26.78x

PBYI2.91x

Quick Ratio (TTM)

ALT26.37x

PBYI2.57x

Debt/Equity (TTM)

ALT0.07x

PBYI0.17x

Debt/Assets (TTM)

ALT0.0%

PBYI0.0%

Interest Coverage (TTM)

ALTN/A

PBYIN/A

Net Debt/EBITDA (TTM)

ALT0.00x

PBYI0.00x

Beta

ALT0.06

PBYI1.36

52W Performance

ALT-33.6%

PBYI96.7%

YTD Performance

ALT-25.6%

PBYI78.3%

% from 52W High

ALT-59.5%

PBYI-0.8%

% from 52W Low

ALT2.4%

PBYI124.7%

Asset Turnover (TTM)

ALT0.00x

PBYI1.15x

FCF Yield (TTM)

ALT-15.1%

PBYI7.8%

Earnings Yield (TTM)

ALT-18.1%

PBYI5.1%

Dividend Yield (TTM)

ALTN/A

PBYIN/A

Rule of 40

ALT-246,919.2

PBYI14.9

EV/GP/RG

ALTN/A

PBYIN/A

Ticker research

View ALT research View PBYI research

Metric	ALT Altimmune Inc	PBYI Puma Biotechnology Inc
Market & Valuation
Market Cap	$508M	$524M
Enterprise Value	$479M	$487M
Price	$2.61	$10.29
P/E Ratio	N/A	20.26x
P/S Ratio	16,373.12x	2.26x
EV/Sales	15,461.31x	2.11x
EV/EBITDA	0.00x	10.51x
P/B Ratio	1.12x	3.54x
P/FCF Ratio	N/A	12.75x
EV/FCF	-6.26x	11.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$31K	$231M
Revenue Growth (YoY)	55.0%	-2.9%
Forward Rev Growth	217.1%	-1.4%
Profitability
Gross Margin (TTM)	0.0%	74.8%
Operating Margin (TTM)	0.0%	13.2%
EBITDA Margin (TTM)	-322987.1%	17.7%
Net Margin (TTM)	-296000.0%	11.6%
FCF Margin (TTM)	-246974.2%	17.8%
Net Income (TTM)	$-92M	$27M
FCF (TTM)	$-77M	$41M
EPS (TTM)	-$0.49	$0.51
ROE (TTM)	-3141.0%	20.8%
ROA (TTM)	-2696.0%	13.3%
ROIC (TTM)	-2853.0%	18.4%
Financial Health
Cash	$63M	$37M
Debt	$35M	$0
Net Cash/Debt	$28M	$37M
Current Ratio (TTM)	26.78x	2.91x
Quick Ratio (TTM)	26.37x	2.57x
Debt/Equity (TTM)	0.07x	0.17x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	1.36
52W Performance	-33.6%	96.7%
YTD Performance	-25.6%	78.3%
% from 52W High	-59.5%	-0.8%
% from 52W Low	2.4%	124.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.15x
FCF Yield (TTM)	-15.1%	7.8%
Earnings Yield (TTM)	-18.1%	5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-246,919.2	14.9
EV/GP/RG	N/A	N/A
Ticker research	View ALT research	View PBYI research

Valuation

P/E Ratio

PBYI

20.26x

P/S Ratio

PBYI

2.26x

ALT

16,373.12x

EV/FCF

ALT

-6.26x

PBYI

11.86x

Growth & revenue

Revenue Growth TTM

ALT

55.0%

PBYI

-2.9%

Forward Revenue Growth

ALT

217.1%

PBYI

-1.4%

Profitability & performance

Gross Margin

PBYI

74.8%

ALT

0.0%

ROE

PBYI

20.8%

ALT

-3141.0%

FCF Yield %

PBYI

7.8%

ALT

-15.1%

52-Week Performance

PBYI

96.7%

ALT

-33.6%

Detailed metrics comparison

ALT

Altimmune Inc

PBYI

Puma Biotechnology Inc

Market Cap

ALT$508M

PBYI$524M

Enterprise Value

ALT$479M

PBYI$487M

Price

ALT$2.61

PBYI$10.29

P/E Ratio

ALTN/A

PBYI20.26x

P/S Ratio

ALT16,373.12x

PBYI2.26x

EV/Sales

ALT15,461.31x

PBYI2.11x

EV/EBITDA

ALT0.00x

PBYI10.51x

P/B Ratio

ALT1.12x

PBYI3.54x

P/FCF Ratio

ALTN/A

PBYI12.75x

EV/FCF

ALT-6.26x

PBYI11.86x

PEG Ratio

ALTN/A

PBYIN/A

Forward P/E (NTM)

ALTN/A

PBYIN/A

Forward P/S (NTM)

ALTN/A

PBYIN/A

Revenue (TTM)

ALT$31K

PBYI$231M

Revenue Growth (YoY)

ALT55.0%

PBYI-2.9%

Forward Rev Growth

ALT217.1%

PBYI-1.4%

Gross Margin (TTM)

ALT0.0%

PBYI74.8%

Operating Margin (TTM)

ALT0.0%

PBYI13.2%

EBITDA Margin (TTM)

ALT-322987.1%

PBYI17.7%

Net Margin (TTM)

ALT-296000.0%

PBYI11.6%

FCF Margin (TTM)

ALT-246974.2%

PBYI17.8%

Net Income (TTM)

ALT$-92M

PBYI$27M

FCF (TTM)

ALT$-77M

PBYI$41M

EPS (TTM)

ALT-$0.49

PBYI$0.51

ROE (TTM)

ALT-3141.0%

PBYI20.8%

ROA (TTM)

ALT-2696.0%

PBYI13.3%

ROIC (TTM)

ALT-2853.0%

PBYI18.4%

Cash

ALT$63M

PBYI$37M

Debt

ALT$35M

PBYI$0

Net Cash/Debt

ALT$28M

PBYI$37M

Current Ratio (TTM)

ALT26.78x

PBYI2.91x

Quick Ratio (TTM)

ALT26.37x

PBYI2.57x

Debt/Equity (TTM)

ALT0.07x

PBYI0.17x

Debt/Assets (TTM)

ALT0.0%

PBYI0.0%

Interest Coverage (TTM)

ALTN/A

PBYIN/A

Net Debt/EBITDA (TTM)

ALT0.00x

PBYI0.00x

Beta

ALT0.06

PBYI1.36

52W Performance

ALT-33.6%

PBYI96.7%

YTD Performance

ALT-25.6%

PBYI78.3%

% from 52W High

ALT-59.5%

PBYI-0.8%

% from 52W Low

ALT2.4%

PBYI124.7%

Asset Turnover (TTM)

ALT0.00x

PBYI1.15x

FCF Yield (TTM)

ALT-15.1%

PBYI7.8%

Earnings Yield (TTM)

ALT-18.1%

PBYI5.1%

Dividend Yield (TTM)

ALTN/A

PBYIN/A

Rule of 40

ALT-246,919.2

PBYI14.9

EV/GP/RG

ALTN/A

PBYIN/A

Ticker research

View ALT research View PBYI research

Metric	ALT Altimmune Inc	PBYI Puma Biotechnology Inc
Market & Valuation
Market Cap	$508M	$524M
Enterprise Value	$479M	$487M
Price	$2.61	$10.29
P/E Ratio	N/A	20.26x
P/S Ratio	16,373.12x	2.26x
EV/Sales	15,461.31x	2.11x
EV/EBITDA	0.00x	10.51x
P/B Ratio	1.12x	3.54x
P/FCF Ratio	N/A	12.75x
EV/FCF	-6.26x	11.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$31K	$231M
Revenue Growth (YoY)	55.0%	-2.9%
Forward Rev Growth	217.1%	-1.4%
Profitability
Gross Margin (TTM)	0.0%	74.8%
Operating Margin (TTM)	0.0%	13.2%
EBITDA Margin (TTM)	-322987.1%	17.7%
Net Margin (TTM)	-296000.0%	11.6%
FCF Margin (TTM)	-246974.2%	17.8%
Net Income (TTM)	$-92M	$27M
FCF (TTM)	$-77M	$41M
EPS (TTM)	-$0.49	$0.51
ROE (TTM)	-3141.0%	20.8%
ROA (TTM)	-2696.0%	13.3%
ROIC (TTM)	-2853.0%	18.4%
Financial Health
Cash	$63M	$37M
Debt	$35M	$0
Net Cash/Debt	$28M	$37M
Current Ratio (TTM)	26.78x	2.91x
Quick Ratio (TTM)	26.37x	2.57x
Debt/Equity (TTM)	0.07x	0.17x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	1.36
52W Performance	-33.6%	96.7%
YTD Performance	-25.6%	78.3%
% from 52W High	-59.5%	-0.8%
% from 52W Low	2.4%	124.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.15x
FCF Yield (TTM)	-15.1%	7.8%
Earnings Yield (TTM)	-18.1%	5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-246,919.2	14.9
EV/GP/RG	N/A	N/A
Ticker research	View ALT research	View PBYI research